BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25247851)

  • 1. Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test.
    Choi SW; Maiga M; Maiga MC; Atudorei V; Sharp ZD; Bishai WR; Timmins GS
    Nat Commun; 2014 Sep; 5():4989. PubMed ID: 25247851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of novel
    Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
    Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
    Zhao X; Yu H; Yu S; Wang F; Sacchettini JC; Magliozzo RS
    Biochemistry; 2006 Apr; 45(13):4131-40. PubMed ID: 16566587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
    Brossier F; Boudinet M; Jarlier V; Petrella S; Sougakoff W
    Tuberculosis (Edinb); 2016 Sep; 100():15-24. PubMed ID: 27553406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).
    Suarez J; Ranguelova K; Schelvis JPM; Magliozzo RS
    J Biol Chem; 2009 Jun; 284(24):16146-16155. PubMed ID: 19363028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular details of INH-C10 binding to wt KatG and Its S315T mutant.
    Teixeira VH; Ventura C; Leitão R; Ràfols C; Bosch E; Martins F; Machuqueiro M
    Mol Pharm; 2015 Mar; 12(3):898-909. PubMed ID: 25590860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.
    Jassal MS; Nedeltchev GG; Lee JH; Choi SW; Atudorei V; Sharp ZD; Deretic V; Timmins GS; Bishai WR
    PLoS One; 2010 Aug; 5(8):e12451. PubMed ID: 20805989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.
    Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y
    Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.
    Cade CE; Dlouhy AC; Medzihradszky KF; Salas-Castillo SP; Ghiladi RA
    Protein Sci; 2010 Mar; 19(3):458-74. PubMed ID: 20054829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular investigation of active binding site of isoniazid (INH) and insight into resistance mechanism of S315T-MtKatG in Mycobacterium tuberculosis.
    Srivastava G; Tripathi S; Kumar A; Sharma A
    Tuberculosis (Edinb); 2017 Jul; 105():18-27. PubMed ID: 28610784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Grzeszczuk M; Kamiński M; Roeske K; Napiórkowska A; Stachowiak R; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    Pneumonol Alergol Pol; 2013; 81(4):298-307. PubMed ID: 23744165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis.
    Unissa AN; Doss C GP; Kumar T; Sukumar S; Lakshmi AR; Hanna LE
    J Glob Antimicrob Resist; 2018 Dec; 15():111-120. PubMed ID: 29990547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.
    Reingewertz TH; Meyer T; McIntosh F; Sullivan J; Meir M; Chang YF; Behr MA; Barkan D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
    Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
    J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance.
    Yu S; Girotto S; Lee C; Magliozzo RS
    J Biol Chem; 2003 Apr; 278(17):14769-75. PubMed ID: 12586821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation.
    Purkan ; Ihsanawati ; Natalia D; Syah YM; Retnoningrum DS; Kusuma HS
    Ukr Biochem J; 2016; 88(5):71-81. PubMed ID: 29235814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium tuberculosis by DeepMelt Assay.
    Liang B; Tan Y; Li Z; Tian X; Du C; Li H; Li G; Yao X; Wang Z; Xu Y; Li Q
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29118176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.
    Dalla Costa ER; Ribeiro MO; Silva MS; Arnold LS; Rostirolla DC; Cafrune PI; Espinoza RC; Palaci M; Telles MA; Ritacco V; Suffys PN; Lopes ML; Campelo CL; Miranda SS; Kremer K; da Silva PE; Fonseca Lde S; Ho JL; Kritski AL; Rossetti ML
    BMC Microbiol; 2009 Feb; 9():39. PubMed ID: 19228426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR.
    Gupta A; Prakash P; Singh SK; Anupurba S
    J Clin Lab Anal; 2013 Jan; 27(1):31-7. PubMed ID: 23325741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.